US 12336995
Combination therapies
granted A61KA61K31/517A61K31/519
Quick answer
US patent 12336995 (Combination therapies) held by Mirati Therapeutics, Inc. expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/517, A61K31/519, A61K31/5377, A61K31/5386